Testing was performed at abbott diagnostics (b)(6) on retained kit lots: 106477, 107755, 108399, 109469, 110100, 109895, 108250, and 108941 with the following internal whole blood and serum/plasma: (b)(6).All test results were valid and performed as expected.Additionally, the manufacturing batch records for lots 106477, 107755, 108399, 109469, 110100, 109895, 108250, and 108941 were reviewed.These lots met the required release specifications.A review of the complaints reported as false positive related to the below lot numbers showed that the complaint rate is: kit lot:106477 - (b)(4).Kit lot 107755 - (b)(4).Kit lot 108399 - (b)(4).Kit lot 109469 - (b)(4).Kit lot 110100 - (b)(4).Kit lot 109895 - (b)(4).Kit lot 108250 - (b)(4).Kit lot 108941 - (b)(4).The evidence available does not indicate that the product is performing outside label claims.Abbott diagnostics (b)(6) was unable to determine the exact root cause of the reported issue.The results obtained may possibly be related to the patient sample.The sample may have contained specific substances which may have affected the results.The available evidence suggests that this device lot is performing within labeled claims.
|